Key result
Hepatic artery ligation plus adriamycin shrinks hepatomas temporarily but triggers fatal cardiotoxicity.
Case Report (n=2)
Answers are grounded in this paper and cite their sources.
Two patients with hepatoma of the liver were treated with ligation of the hepatic artery and continuous infusion of adriamycin into the distal arterial branch. Both patients had tumor replacing 60-75% of the normal liver parenchyma. There was clinical improvement and objective shrinkage of the tumor by liver scan lasting for 5 and 7 months. But both cases died 7 and 11 months later, probably of cardiac toxicity (total dose of adriamycin = 500 mg/m2).
No takes yet. Share an insight, caveat, or question.
Lee et al. (1978) conducted a case report in Hepatoma of the liver (n=2). Hepatic artery ligation and continuous adriamycin infusion into the distal arterial branch was evaluated on Clinical improvement and objective tumor shrinkage by liver scan. Hepatic artery ligation with adriamycin infusion produced tumor shrinkage for 5 and 7 months in 2 hepatoma patients, though both died at 7 and 11 months likely from cardiac toxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: